Application of Carnoy's Solution in Adjuvant Treatment of Jaw Cystic Lesions: A Review

doi:10.13701/j.cnki.kqyxyj.2023.12.004

Abstract

Abstract: Odontogenic keratocysts and unicystic ameloblastomas are common benign lesions of the jaw but are locally aggressive. The above-mentioned lesions are all prone to occur in adolescents, and are more common in the posterior part of the jaw or the ascending ramus. Due to the limited field of view in the operation area and the high invasion ability of the lesion itself, there is often a high postoperative recurrence rate after simple curettage or decompression, and surgical methods combined with adjuvant therapy such as physical or chemical treatment can significantly reduce the recurrence. Carnoy's solution is a chemical fixative used early in clinical practice. Carnoy's solution has been widely verified in the adjuvant treatment of cystic lesions of the jaw, especially odontogenic keratocyst. However, some clinicians still have concerns about the indications and safety of the clinical application of Carnoy's solution. This review introduces the principle, effectiveness, and safety of Carnoy's solution and its modified patterns in treatment of jaw cystic lesions.

Key words: Carnoy's solution, odontogenic keratocyst, ameloblastoma, recur, adjuvant treatment

MAN Qiwen, WANG Hanqi. Application of Carnoy's Solution in Adjuvant Treatment of Jaw Cystic Lesions: A Review[J]. Journal of Oral Science Research, 2023, 39(12): 1046-1049.

References

[1] 段聪聪,韩冰.颌骨囊性病变相关手术治疗的发展现状[J].口腔医学研究,2020,36(10):898-901.
[2] Gomes IP, Bastos VC, Guimarães LM,et al. The molecular basis of odontogenic cysts and tumours? [J]. J Oral Pathol Med, 2023, 52(4): 351-356.
[3] Ecker J, Horst Rt, Koslovsky D. Current role of Carnoy's solution in treating keratocystic odontogenic tumors [J]. J Oral Maxillofac Surg, 2016, 74(2):278-282.
[4] Lebedev VV, Butsan SB. The use of Carnoy’s solution and its modifications for reducing the number of recurrences after surgical removal of keratocystic odontogenic tumors and ameloblastomas: A systematic review [J]. Moscow Univ Biol Sci Bull, 2019, 74(2):108-116.
[5] Cutler EC, Zollinger R. The use of sclerosing solutions in the treatment of cysts and fistulae [J]. Am J Surg, 1933, 19(3):411-418.
[6] Wahab MM, Abdul DPU. Carnoy's solution as a surgical medicament in the treatment of keratocystic odontogenic tumour [J]. Int J Pharma Bio Sci, 2014, 5(1):B492-B495.
[7] Puchtler H, Waldrop FS, Conner HM, et al. Carnoy fixation: practical and theoretical considerations [J]. Histochemie, 1968, 16 (4):361-371.
[8] Carvalho FSR, Feitosa VP, da Cruz Fonseca SG, et al. Physicochemical and rheological characterization of different Carnoy's solutions applied in oral and maxillofacial surgery [J]. J Raman Spectrosc, 2017, 48 (10):1375-1384.
[9] Carvalho F, Feitosa V, Silva P, et al. Evaluation of different therapeutic Carnoy's formulations on hard human tissues: A Raman microspectroscopy, microhardness, and scanning electron microscopy study [J]. J Craniomaxillofac Surg, 2018, 46(5):749-758.
[10] Dashow JE, McHugh JB, Braun TM, et al. Significantly decreased recurrence rates in keratocystic odontogenic tumor with simple enucleation and curettage using Carnoy's versus modified Carnoy's solution [J]. J Oral Maxillofac Surg, 2015, 73(11):2132-2135.
[11] Karacai R, Uluğ B, Kodaz T, et al. Regarding "Significantly decreased recurrence rates in keratocystic odontogenic tumor with simple enucleation and curettage using Carnoy's versus modified Carnoy's solution" [J]. J Oral Maxillofac Surg,2016, 74(6):1103-1104.
[12] Donnelly LA, Simmons TH, Blitstein BJ, et al. Modified Carnoy's compared to Carnoy's solution is equally effective in preventing recurrence of odontogenic keratocysts [J]. J Oral Maxillofac Surg,2021, 79(9):1874-1881.
[13] Janas-Naze A, Zhang W, Szuta M. Modified Carnoy's versus Carnoy's solution in the management of odontogenic keratocysts-A single center experience [J]. J Clin Med, 2023, 12(3):1133.
[14] Man QW. A survey on the application of Carnoy's solution in China [J]. Adv Oral Maxillofac Surg,2023,10:100412.
[15] Fidele NB, Zhao YF, Wu TF, et al.Treatment of multiple odontogenic keratocysts involving Chinese patients [J]. J Oral Maxillofac Surg, 2019, 77(10):2044-2054.
[16] Malci A, Juki S, Ani I, et al. Alterations of FHIT and P53 genes in keratocystic odontogenic tumor, dentigerous and radicular cyst [J]. J Oral Pathol Med, 2008, 37(5):294-301.
[17] 刘冰,何悦,彭歆,等.牙源性角化囊肿诊疗中国专家共识[J].中国口腔颌面外科杂志,2022,20(3):209-218.
[18] Johnson N, Batstone M, Savage N. Management and recurrence of keratocystic odontogenic tumor: a systematic review [J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2013, 116(4):e271-e276.
[19] Chrcanovic B, Gomez R. Recurrence probability for keratocystic odontogenic tumors: An analysis of 6427 cases [J]. J Craniomaxillofac Surg,2017, 45(2):244-251.
[20] Fidele NB, Zheng YY, Zhao Y, et al. Recurrence of odontogenic keratocysts and possible prognostic factors: Review of 455 patients [J]. Med Oral Patol Oral Cir Bucal, 2019, 24(4):e491-e501.
[21] Effiom OA, Ogundana OM, Akinshipo AO, et al. Ameloblastoma: current etiopathological concepts and management [J]. Oral Dis, 2018, 24(3):307-316.
[22] El-Naggar AK CJ, Grandis JR, Takata T, et al. WHO classification of head and neck tumours. El-Naggar AK.WHO Classification of Tumours[S].4th edition.9. Lyon, France: World Health Organization, 2017: 203-260.
[23] Lee P, Samman N, Ng I. Unicystic ameloblastoma--use of Carnoy's solution after enucleation [J]. Int J Oral Maxillofac Surg, 2004, 33(3):263-267.
[24] Rajeshkumar BP, Rai KK, Geetha NT, et al. Carnoy's in aggressive lesions: Our experience [J]. J Maxillofac Oral Surg, 2013, 12(1):42-47.
[25] Liu C, Samani M, Kwok J, et al. Conservative management of botryoid odontogenic cysts using Carnoy's solution [J]. Br J Oral Maxillofac Surg, 2020, 58(2):245-247.
[26] Frerich B, Cornelius CP, Wiethölter H. Critical time of exposure of the rabbit inferior alveolar nerve to Carnoy's solution [J]. J Oral Maxillofac Surg, 1994, 52(6):599-606.
[27] Saulacic N, Stajcic Z, Stojcev Stajcic L, et al. Effects of Carnoy's solution on blood vessels of the axillary fossa of rats [J]. Int J Oral Maxillofac Surg, 2009, 38(8):876-879.
[28] Sivanmalai S, Kandhasamy K, Prabu N, et al. Carnoy's solution in the mangement of odontogenic keratocyst [J]. J Pharm Bioallied Sci, 2012, 4(Suppl 2):S183-S185.
[29] Jo HJ, Kim HY, Kang DC, et al. A clinical study of inferior alveolar nerve damage caused by Carnoy's solution used as a complementary therapeutic agent in a cystic lesion [J]. Maxillofac Plast Reconstr Surg, 2020, 42(1):16.
[30] Carvalho FSR, Feitosa VP, Silva PGB, et al. Evaluation of different therapeutic Carnoy's formulations on hard human tissues: A Raman microspectroscopy, microhardness, and scanning electron microscopy study [J]. J Craniomaxillofac Surg, 2018, 46(5):749-758.
[31] Slusarenko da Silva Y, Stoelinga PJW, Naclério-Homem MG. Immediate and late effects of Carnoy's solution on the mandibular bone of Wistar rats [J]. Oral Surg, 2019, 12(2):104-109.
[32] Ribeiro Junior O, Borba AM, Alves CA, et al. Keratocystic odontogenic tumors and Carnoy's solution: results and complications assessment [J]. Oral Dis, 2012,18(6):548-557.